Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata

被引：0

作者：

Shapiro, Jerry ^{[1
]}

Ko, Justin ^{[2
]}

Egeberg, Alexander ^{[3
]}

Somani, Najwa ^{[4
]}

Jedynak, Jakub ^{[4
]}

Torisu-Itakura, Hitoe ^{[4
]}

Yu, Guanglei ^{[4
]}

Lu, Na ^{[5
]}

Craiglow, Brittany ^{[6
]}

机构：

[1] New York Univ, Grossman Sch Med, New York, NY USA

[2] Stanford Med, Stanford, CA USA

[3] Copenhagen Univ Hosp Bispebjerg, Copenhagen, Denmark

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Precis Stat Consulting, Woodbury, MN USA

[6] Yale Sch Med, New Haven, CT USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

41247

引用

页码：AB127 / AB127

页数：1

共 50 条

[41] Characteristics of induced alopecia areata-like hair loss in C3H/HeJ mice are consistent with a T cell mediated disruption of anagen hair follicles
McElwee, K
Carroll, J
Boggess, D
Silva, K
King, L
Sundberg, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 644 - 644
[42] Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone
Shapiro, J
Sundberg, JP
Bissonnette, R
McElwee, KJ
McLean, DI
Carroll, JM
Oliver, RF
Tang, LR
Lui, H
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 1999, 4 (03) : 239 - 239
[43] Anti-CD44v10 inhibits alopecia areata-like hair loss in C3H/HeJ mice
Freyschmidt-Paul, P
Seiter, S
Zöller, M
Sundberg, J
König, A
Happle, R
Hoffmann, R
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 555 - 555
[44] Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss
McElwee, KJ
Silva, K
Boggess, D
Bechtold, L
King, LE
Sundberg, JP
VETERINARY PATHOLOGY, 2003, 40 (06) : 643 - 650
[45] Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice
Freyschmidt-Paul, P
Sundberg, JP
Happle, R
McElwee, KJ
Metz, S
Boggess, D
Hoffmann, R
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (01) : 61 - 68
[46] Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts
McElwee, KJ
Boggess, D
King, LE
Sundberg, JP
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) : 797 - 803
[47] Quantitative analysis of hair loss in mice utilizing imageJ improves the efficacy evaluation of alopecia areata induction in the C3H/HeJ mouse model
Chen, L.
Low, S. A.
Senna, M. M.
Gregory-Ksander, M. S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S33 - S33
[48] Efficacy and safety of ritlecitinib (PF06651600) in patients with alopecia areata and at least 50% scalp hair loss: results from the international ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled study (NCT03732807)
King, Brett
Zhang, Xingqi
Gubelin, Walter
Szepietowski, Jacek
Shapiro, Jerry
Lynde, Charles
Mesinkovska, Natasha
Zwillich, Samuel
Napatalung, Lynne
Wajsbrot, Dalia
Fayyad, Rana
Freyman, Amy
Mitra, Debanjali
Purohit, Vivek
Sinclair, Rodney
Wolk, Robert
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 125 - 125
[49] Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
Sinclair, Rodney
Mesinkovska, Natasha
Mitra, Debanjali
Wajsbrot, Dalia
Law, Ernest H.
Wolk, Robert
King, Brett
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (01) : 109 - 119
[50] Improvement in patient-reported hair loss outcome measures in patients with alopecia areata treated with ritlecitinib: 48-week results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial
Sinclair, Rodney
Mesinkovska, Natasha
Mitra, Debanjali
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB69 - AB69

← 1 2 3 4 5 →